Patents by Inventor Haley L. Dugan

Haley L. Dugan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12180267
    Abstract: Provided herein are anti-neuraminidase agents useful for neutralization of influenza virus infection, and methods of use and manufacture thereof. In particular, compositions comprising anti-neuraminidase agents (e.g., antibodies) that are cross-reactive with multiple influenza strains are provided, as well as methods of treatment and prevention of influenza infection therewith.
    Type: Grant
    Filed: June 15, 2023
    Date of Patent: December 31, 2024
    Assignee: The University of Chicago
    Inventors: Patrick Wilson, Yaoqing Chen, Haley L. Dugan
  • Patent number: 12139527
    Abstract: Provided herein are anti-neuraminidase agents useful for neutralization of influenza virus infection, and methods of use and manufacture thereof. In particular, compositions comprising anti-neuraminidase agents (e.g., antibodies) that are cross-reactive with multiple influenza strains are provided, as well as methods of treatment and prevention of influenza infection therewith.
    Type: Grant
    Filed: June 15, 2023
    Date of Patent: November 12, 2024
    Assignee: The University of Chicago
    Inventors: Patrick Wilson, Yaoqing Chen, Haley L. Dugan
  • Patent number: 12134641
    Abstract: Provided herein are anti-neuraminidase agents useful for neutralization of influenza virus infection, and methods of use and manufacture thereof. In particular, compositions comprising anti-neuraminidase agents (e.g., antibodies) that are cross-reactive with multiple influenza strains are provided, as well as methods of treatment and prevention of influenza infection therewith.
    Type: Grant
    Filed: June 15, 2023
    Date of Patent: November 5, 2024
    Assignee: The University of Chicago
    Inventors: Patrick Wilson, Yaoqing Chen, Haley L. Dugan
  • Patent number: 12077574
    Abstract: Provided herein are anti-neuraminidase agents useful for neutralization of influenza virus infection, and methods of use and manufacture thereof. In particular, compositions comprising anti-neuraminidase agents (e.g., antibodies) that are cross-reactive with multiple influenza strains are provided, as well as methods of treatment and prevention of influenza infection therewith.
    Type: Grant
    Filed: June 15, 2023
    Date of Patent: September 3, 2024
    Assignee: The University of Chicago
    Inventors: Patrick Wilson, Yaoqing Chen, Haley L. Dugan
  • Patent number: 12077573
    Abstract: Provided herein are anti-neuraminidase agents useful for neutralization of influenza virus infection, and methods of use and manufacture thereof. In particular, compositions comprising anti-neuraminidase agents (e.g., antibodies) that are cross-reactive with multiple influenza strains are provided, as well as methods of treatment and prevention of influenza infection therewith.
    Type: Grant
    Filed: June 15, 2023
    Date of Patent: September 3, 2024
    Assignee: The University of Chicago
    Inventors: Patrick Wilson, Yaoqing Chen, Haley L. Dugan
  • Publication number: 20240117015
    Abstract: Provided herein are anti-neuraminidase agents useful for neutralization of influenza virus infection, and methods of use and manufacture thereof In particular, compositions comprising anti-neuraminidase agents (e.g., antibodies) that are cross-reactive with multiple influenza strains are provided, as well as methods of treatment and prevention of influenza infection therewith.
    Type: Application
    Filed: June 15, 2023
    Publication date: April 11, 2024
    Inventors: Patrick Wilson, Yaoqing Chen, Haley L. Dugan
  • Publication number: 20240117013
    Abstract: Provided herein are anti-neuraminidase agents useful for neutralization of influenza virus infection, and methods of use and manufacture thereof. In particular, compositions comprising anti-neuraminidase agents (e.g., antibodies) that are cross-reactive with multiple influenza strains are provided, as well as methods of treatment and prevention of influenza infection therewith.
    Type: Application
    Filed: June 15, 2023
    Publication date: April 11, 2024
    Inventors: Patrick Wilson, Yaoqing Chen, Haley L. Dugan
  • Publication number: 20240117016
    Abstract: Provided herein are anti-neuraminidase agents useful for neutralization of influenza virus infection, and methods of use and manufacture thereof. In particular, compositions comprising anti-neuraminidase agents (e.g., antibodies) that are cross-reactive with multiple influenza strains are provided, as well as methods of treatment and prevention of influenza infection therewith.
    Type: Application
    Filed: June 15, 2023
    Publication date: April 11, 2024
    Inventors: Patrick Wilson, Yaoqing Chen, Haley L. Dugan
  • Publication number: 20240117014
    Abstract: Provided herein are anti-neuraminidase agents useful for neutralization of influenza virus infection, and methods of use and manufacture thereof In particular, compositions comprising anti-neuraminidase agents (e.g., antibodies) that are cross-reactive with multiple influenza strains are provided, as well as methods of treatment and prevention of influenza infection therewith.
    Type: Application
    Filed: June 15, 2023
    Publication date: April 11, 2024
    Inventors: Patrick Wilson, Yaoqing Chen, Haley L. Dugan
  • Publication number: 20240002478
    Abstract: Provided herein are anti-neuraminidase agents useful for neutralization of influenza virus infection, and methods of use and manufacture thereof. In particular, compositions comprising anti-neuraminidase agents (e.g., antibodies) that are cross-reactive with multiple influenza strains are provided, as well as methods of treatment and prevention of influenza infection therewith.
    Type: Application
    Filed: June 15, 2023
    Publication date: January 4, 2024
    Inventors: Patrick Wilson, Yaoqing Chen, Haley L. Dugan
  • Patent number: 11702464
    Abstract: Provided herein are anti-neuraminidase agents useful for neutralization of influenza virus infection, and methods of use and manufacture thereof. In particular, compositions comprising anti-neuraminidase agents (e.g., antibodies) that are cross-reactive with multiple influenza strains are provided, as well as methods of treatment and prevention of influenza infection therewith.
    Type: Grant
    Filed: March 1, 2019
    Date of Patent: July 18, 2023
    Assignee: The University of Chicago
    Inventors: Patrick Wilson, Yaoqing Chen, Haley L. Dugan
  • Publication number: 20210002354
    Abstract: Provided herein are anti-neuraminidase agents useful for neutralization of influenza virus infection, and methods of use and manufacture thereof. In particular, compositions comprising anti-neuraminidase agents (e.g., antibodies) that are cross-reactive with multiple influenza strains are provided, as well as methods of treatment and prevention of influenza infection therewith.
    Type: Application
    Filed: March 1, 2019
    Publication date: January 7, 2021
    Inventors: Patrick Wilson, Yaoqing Chen, Haley L. Dugan